Metabolic Syndrome in Post-Pulmonary Tuberculosis-Associated Obstructive Airway Disease: A Cross-Sectional Analytical Study

Background The aim of this study is to assess the prevalence of metabolic syndrome in tuberculosis-associated obstructive airway disease (TOPD) patients, as well as the association of its components with the severity of airflow obstruction. Methodology In this cross-sectional analytical study, we ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2022-03, Vol.14 (3), p.e23640-e23640
Hauptverfasser: Mp, Shahana, Mohanty Mohapatra, Madhusmita, Mahesh Babu, Vemuri, Rajaram, Manju, Rajaa, Sathish, Gandhipuram Periyasamy, Senthil Kumar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e23640
container_issue 3
container_start_page e23640
container_title Curēus (Palo Alto, CA)
container_volume 14
creator Mp, Shahana
Mohanty Mohapatra, Madhusmita
Mahesh Babu, Vemuri
Rajaram, Manju
Rajaa, Sathish
Gandhipuram Periyasamy, Senthil Kumar
description Background The aim of this study is to assess the prevalence of metabolic syndrome in tuberculosis-associated obstructive airway disease (TOPD) patients, as well as the association of its components with the severity of airflow obstruction. Methodology In this cross-sectional analytical study, we evaluated the clinical profile, spirometry, waist circumference, blood pressure, lipid profile, fasting plasma glucose, and the association of each component with the severity of airflow obstruction. Results The prevalence of metabolic syndrome in TOPD was found to be was 25.77% (95% confidence interval = 18.11-35.28) among study participants. Reduced high-density lipoprotein was the deranged component and was associated with increased severity in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II compared to GOLD stage IV. Conclusions The prevalence of metabolic syndrome in TOPD has a severe impact on patients' treatment, outcomes, and complications. However, in our study, tuberculosis-associated metabolic syndrome was the same as the general population. Low high-density lipoprotein levels were associated with the severity of the airflow obstruction.
doi_str_mv 10.7759/cureus.23640
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9051989</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2671840400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-749af61783ca6ee3feefcfbd88977e63485f1ba1076f8852a84cab5f3c526db43</originalsourceid><addsrcrecordid>eNpdkU1rFTEUhgdRbKnduZaAGxedmpl8jgthuGoVKi3cug6ZzImmzExqPiqDf97c3lqqm-TAeXjJm6eqXjb4VAjWvTU5QI6nLeEUP6kO24bLWjaSPn00H1THMV5jjBssWizw8-qAMIaZoPiw-v0Vkh785AzarssY_AzILejSx1Rf5mn2iw4rusoDBJMnH12s-xi9cTrBiC6GmEI2yd0C6l34pVf0wUXQEd6hHm2Cj7HeQtmXmAn15ViTM2XcpjyuL6pnVk8Rju_vo-rbp49Xm8_1-cXZl01_XhtC21QL2mnLGyGJ0RyAWABr7DBK2QkBnFDJbDPo0o5bKVmrJTV6YJYY1vJxoOSoer_PvcnDDKOBJQU9qZvg5lJOee3Uv5vF_VDf_a3qMGs62ZWAN_cBwf_MEJOaXTQwTXoBn6NqOes4ph1lBX39H3rtcyjFd5QoNjDFuFAne8rsviiAfXhMg9VOrNqLVXdiC_7qcYEH-K9G8gd_5aLa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2671840400</pqid></control><display><type>article</type><title>Metabolic Syndrome in Post-Pulmonary Tuberculosis-Associated Obstructive Airway Disease: A Cross-Sectional Analytical Study</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Mp, Shahana ; Mohanty Mohapatra, Madhusmita ; Mahesh Babu, Vemuri ; Rajaram, Manju ; Rajaa, Sathish ; Gandhipuram Periyasamy, Senthil Kumar</creator><creatorcontrib>Mp, Shahana ; Mohanty Mohapatra, Madhusmita ; Mahesh Babu, Vemuri ; Rajaram, Manju ; Rajaa, Sathish ; Gandhipuram Periyasamy, Senthil Kumar</creatorcontrib><description>Background The aim of this study is to assess the prevalence of metabolic syndrome in tuberculosis-associated obstructive airway disease (TOPD) patients, as well as the association of its components with the severity of airflow obstruction. Methodology In this cross-sectional analytical study, we evaluated the clinical profile, spirometry, waist circumference, blood pressure, lipid profile, fasting plasma glucose, and the association of each component with the severity of airflow obstruction. Results The prevalence of metabolic syndrome in TOPD was found to be was 25.77% (95% confidence interval = 18.11-35.28) among study participants. Reduced high-density lipoprotein was the deranged component and was associated with increased severity in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II compared to GOLD stage IV. Conclusions The prevalence of metabolic syndrome in TOPD has a severe impact on patients' treatment, outcomes, and complications. However, in our study, tuberculosis-associated metabolic syndrome was the same as the general population. Low high-density lipoprotein levels were associated with the severity of the airflow obstruction.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.23640</identifier><identifier>PMID: 35505740</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Age ; Biomass energy ; Blood pressure ; Chronic obstructive pulmonary disease ; Diabetes ; Endocrinology/Diabetes/Metabolism ; Gender ; Infectious Disease ; Lung diseases ; Males ; Metabolic syndrome ; Mortality ; Obesity ; Older people ; Pulmonology ; Smoking ; Spirometry ; Tuberculosis</subject><ispartof>Curēus (Palo Alto, CA), 2022-03, Vol.14 (3), p.e23640-e23640</ispartof><rights>Copyright © 2022, MP et al.</rights><rights>Copyright © 2022, MP et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, MP et al. 2022 MP et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-749af61783ca6ee3feefcfbd88977e63485f1ba1076f8852a84cab5f3c526db43</citedby><cites>FETCH-LOGICAL-c342t-749af61783ca6ee3feefcfbd88977e63485f1ba1076f8852a84cab5f3c526db43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051989/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051989/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35505740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mp, Shahana</creatorcontrib><creatorcontrib>Mohanty Mohapatra, Madhusmita</creatorcontrib><creatorcontrib>Mahesh Babu, Vemuri</creatorcontrib><creatorcontrib>Rajaram, Manju</creatorcontrib><creatorcontrib>Rajaa, Sathish</creatorcontrib><creatorcontrib>Gandhipuram Periyasamy, Senthil Kumar</creatorcontrib><title>Metabolic Syndrome in Post-Pulmonary Tuberculosis-Associated Obstructive Airway Disease: A Cross-Sectional Analytical Study</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Background The aim of this study is to assess the prevalence of metabolic syndrome in tuberculosis-associated obstructive airway disease (TOPD) patients, as well as the association of its components with the severity of airflow obstruction. Methodology In this cross-sectional analytical study, we evaluated the clinical profile, spirometry, waist circumference, blood pressure, lipid profile, fasting plasma glucose, and the association of each component with the severity of airflow obstruction. Results The prevalence of metabolic syndrome in TOPD was found to be was 25.77% (95% confidence interval = 18.11-35.28) among study participants. Reduced high-density lipoprotein was the deranged component and was associated with increased severity in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II compared to GOLD stage IV. Conclusions The prevalence of metabolic syndrome in TOPD has a severe impact on patients' treatment, outcomes, and complications. However, in our study, tuberculosis-associated metabolic syndrome was the same as the general population. Low high-density lipoprotein levels were associated with the severity of the airflow obstruction.</description><subject>Age</subject><subject>Biomass energy</subject><subject>Blood pressure</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Diabetes</subject><subject>Endocrinology/Diabetes/Metabolism</subject><subject>Gender</subject><subject>Infectious Disease</subject><subject>Lung diseases</subject><subject>Males</subject><subject>Metabolic syndrome</subject><subject>Mortality</subject><subject>Obesity</subject><subject>Older people</subject><subject>Pulmonology</subject><subject>Smoking</subject><subject>Spirometry</subject><subject>Tuberculosis</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkU1rFTEUhgdRbKnduZaAGxedmpl8jgthuGoVKi3cug6ZzImmzExqPiqDf97c3lqqm-TAeXjJm6eqXjb4VAjWvTU5QI6nLeEUP6kO24bLWjaSPn00H1THMV5jjBssWizw8-qAMIaZoPiw-v0Vkh785AzarssY_AzILejSx1Rf5mn2iw4rusoDBJMnH12s-xi9cTrBiC6GmEI2yd0C6l34pVf0wUXQEd6hHm2Cj7HeQtmXmAn15ViTM2XcpjyuL6pnVk8Rju_vo-rbp49Xm8_1-cXZl01_XhtC21QL2mnLGyGJ0RyAWABr7DBK2QkBnFDJbDPo0o5bKVmrJTV6YJYY1vJxoOSoer_PvcnDDKOBJQU9qZvg5lJOee3Uv5vF_VDf_a3qMGs62ZWAN_cBwf_MEJOaXTQwTXoBn6NqOes4ph1lBX39H3rtcyjFd5QoNjDFuFAne8rsviiAfXhMg9VOrNqLVXdiC_7qcYEH-K9G8gd_5aLa</recordid><startdate>20220330</startdate><enddate>20220330</enddate><creator>Mp, Shahana</creator><creator>Mohanty Mohapatra, Madhusmita</creator><creator>Mahesh Babu, Vemuri</creator><creator>Rajaram, Manju</creator><creator>Rajaa, Sathish</creator><creator>Gandhipuram Periyasamy, Senthil Kumar</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220330</creationdate><title>Metabolic Syndrome in Post-Pulmonary Tuberculosis-Associated Obstructive Airway Disease: A Cross-Sectional Analytical Study</title><author>Mp, Shahana ; Mohanty Mohapatra, Madhusmita ; Mahesh Babu, Vemuri ; Rajaram, Manju ; Rajaa, Sathish ; Gandhipuram Periyasamy, Senthil Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-749af61783ca6ee3feefcfbd88977e63485f1ba1076f8852a84cab5f3c526db43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Biomass energy</topic><topic>Blood pressure</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Diabetes</topic><topic>Endocrinology/Diabetes/Metabolism</topic><topic>Gender</topic><topic>Infectious Disease</topic><topic>Lung diseases</topic><topic>Males</topic><topic>Metabolic syndrome</topic><topic>Mortality</topic><topic>Obesity</topic><topic>Older people</topic><topic>Pulmonology</topic><topic>Smoking</topic><topic>Spirometry</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mp, Shahana</creatorcontrib><creatorcontrib>Mohanty Mohapatra, Madhusmita</creatorcontrib><creatorcontrib>Mahesh Babu, Vemuri</creatorcontrib><creatorcontrib>Rajaram, Manju</creatorcontrib><creatorcontrib>Rajaa, Sathish</creatorcontrib><creatorcontrib>Gandhipuram Periyasamy, Senthil Kumar</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mp, Shahana</au><au>Mohanty Mohapatra, Madhusmita</au><au>Mahesh Babu, Vemuri</au><au>Rajaram, Manju</au><au>Rajaa, Sathish</au><au>Gandhipuram Periyasamy, Senthil Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic Syndrome in Post-Pulmonary Tuberculosis-Associated Obstructive Airway Disease: A Cross-Sectional Analytical Study</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2022-03-30</date><risdate>2022</risdate><volume>14</volume><issue>3</issue><spage>e23640</spage><epage>e23640</epage><pages>e23640-e23640</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Background The aim of this study is to assess the prevalence of metabolic syndrome in tuberculosis-associated obstructive airway disease (TOPD) patients, as well as the association of its components with the severity of airflow obstruction. Methodology In this cross-sectional analytical study, we evaluated the clinical profile, spirometry, waist circumference, blood pressure, lipid profile, fasting plasma glucose, and the association of each component with the severity of airflow obstruction. Results The prevalence of metabolic syndrome in TOPD was found to be was 25.77% (95% confidence interval = 18.11-35.28) among study participants. Reduced high-density lipoprotein was the deranged component and was associated with increased severity in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II compared to GOLD stage IV. Conclusions The prevalence of metabolic syndrome in TOPD has a severe impact on patients' treatment, outcomes, and complications. However, in our study, tuberculosis-associated metabolic syndrome was the same as the general population. Low high-density lipoprotein levels were associated with the severity of the airflow obstruction.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>35505740</pmid><doi>10.7759/cureus.23640</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2022-03, Vol.14 (3), p.e23640-e23640
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9051989
source PubMed Central; PubMed Central Open Access
subjects Age
Biomass energy
Blood pressure
Chronic obstructive pulmonary disease
Diabetes
Endocrinology/Diabetes/Metabolism
Gender
Infectious Disease
Lung diseases
Males
Metabolic syndrome
Mortality
Obesity
Older people
Pulmonology
Smoking
Spirometry
Tuberculosis
title Metabolic Syndrome in Post-Pulmonary Tuberculosis-Associated Obstructive Airway Disease: A Cross-Sectional Analytical Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T00%3A26%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20Syndrome%20in%20Post-Pulmonary%20Tuberculosis-Associated%20Obstructive%20Airway%20Disease:%20A%20Cross-Sectional%20Analytical%20Study&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Mp,%20Shahana&rft.date=2022-03-30&rft.volume=14&rft.issue=3&rft.spage=e23640&rft.epage=e23640&rft.pages=e23640-e23640&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.23640&rft_dat=%3Cproquest_pubme%3E2671840400%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2671840400&rft_id=info:pmid/35505740&rfr_iscdi=true